Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.455
-0.045 (-1.80%)
Oct 8, 2025, 1:58 PM EDT - Market open
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $564.36 million as of October 8, 2025. Its market cap has increased by 159.91% in one year.
Market Cap
564.36M
Enterprise Value
548.52M
1-Year Change
159.91%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $564.36M, a decrease of -43.30%. That is a compound annual growth rate of -8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 554.01M | 170.27% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | 701.04M | -26.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |